Expression of Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, and Interleukins in Vertebral Cartilage Endplate

被引:39
|
作者
Zhang, Jian-feng [1 ]
Wang, Gang-liang [1 ]
Zhou, Zhi-jie [1 ]
Fang, Xiang-qian [1 ]
Chen, Shuai [1 ]
Fan, Shun-wu [1 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Orthopaed, Med Coll, Hangzhou, Zhejiang, Peoples R China
关键词
Cartilage endplate; Degenerative disc disease; Interleukins; MMP; TIMP; NECROSIS-FACTOR-ALPHA; LOW-BACK-PAIN; OSTEOARTHRITIS; RECEPTOR; GENE; MODULATION; ADAMTS-4;
D O I
10.1111/os.12409
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objective Methods Turnover of cartilage endplate extracellular matrix (ECM) may play an important role in disc degeneration and low back pain (LBP). However, the expression pattern of pro-inflammatory factors, matrix metalloproteinases (MMP), and tissue inhibitors of metalloproteinases (TIMP) in the cartilage endplates (CEP) of intervertebral discs (IVD) is not understood. We aimed to examine the transcriptional levels of MMP, TIMP, and interleukins (IL), and the correlations between them. Thirty degenerated cartilage endplate samples from patients with LBP who underwent lumbar fusion surgery were included in the degenerated group. Ten patients without LBP history who underwent lumbar surgery because of vertebral burst fractures were included in the control group. The degenerative severity of the samples was evaluated by MRI, and hematoxylin-eosin and safranin O-fast green (SO-FG) staining. Real-time polymerase chain reaction (RT-PCR) was used to detect the mRNA levels of MMP-1, MMP-3, MMP-9, MMP-13, TIMP-1, TIMP-2, TIMP-3, IL-1 alpha, IL-1 beta, and IL-6. The correlations between the levels of these genes were tested using Spearman's rho test. Results Conclusion Hematoxylin-eosin and SO-FG staining confirmed a decrease in cell number and proteoglycans in the degenerated cartilage endplate. MRI showed significant signal changes in degenerated cartilage endplates. Patients in the degenerated group showed a higher rate of endplate Modic changes when compared with the control group. MMP-3, MMP-9, TIMP-3, IL-1 alpha, and IL-1 beta were elevated with statistical significance, while MMP-1, MMP-13, TIMP-1, TIMP-2, and IL-6 were changed without statistical significance or remained unchanged. Expression of MMP-3 was positively correlated with IL-1 alpha (Spearman coefficient, 0.486; P < 0.05); expression of TIMP-3 was positively correlated with MMP-9, IL-1 alpha, and IL-1 beta (Spearman coefficient, 0.577, 0.407, and 0.571, respectively; P < 0.05). MMP-3, MMP-9, TIMP-3, IL-1 alpha, and IL-1 beta may play a role in the process of cartilage endplate degeneration. MMP-3 may be regulated by IL-1 alpha, and TIMP-3 might be associated with MMP-9 and regulated by IL-1 alpha and IL-1 beta.
引用
收藏
页码:306 / 311
页数:6
相关论文
共 50 条
  • [21] Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma
    Yamamoto, H
    Itoh, F
    Adachi, Y
    Fukushima, H
    Itoh, H
    Sasaki, S
    Hinoda, Y
    Imai, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (02) : 58 - 62
  • [22] Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines
    Daja, MM
    Niu, X
    Zhao, Z
    Brown, JM
    Russell, PJ
    PROSTATE CANCER AND PROSTATIC DISEASES, 2003, 6 (01) : 15 - 26
  • [23] Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm
    Jin, Dianshi
    Sheng, Jun
    Yang, Xinjian
    Gao, Baoshan
    SURGICAL NEUROLOGY, 2007, 68 : 11 - 17
  • [24] Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases
    Bode, W
    Maskos, K
    BIOLOGICAL CHEMISTRY, 2003, 384 (06) : 863 - 872
  • [25] Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium
    Goffin, F
    Munaut, C
    Frankenne, F
    d'Hauterive, SP
    Béliard, A
    Fridman, V
    Nervo, P
    Colige, A
    Foidart, JM
    BIOLOGY OF REPRODUCTION, 2003, 69 (03) : 976 - 984
  • [26] Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines
    M M Daja
    X Niu
    Z Zhao
    J M Brown
    P J Russell
    Prostate Cancer and Prostatic Diseases, 2003, 6 : 15 - 26
  • [27] Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes
    Agapova, OA
    Ricard, CS
    Salvador-Silva, M
    Hernandez, MR
    GLIA, 2001, 33 (03) : 205 - 216
  • [28] Expression profiling of metalloproteinases and inhibitors in cartilage
    Kevorkian, L
    Young, DA
    Darrah, C
    Donell, ST
    Shepstone, L
    Porter, S
    Brockbank, S
    Edwards, DR
    Parker, AE
    Clark, IM
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (03) : A4 - A4
  • [29] Expression profiling of metalloproteinases and their inhibitors in cartilage
    Kevorkian, L
    Young, DA
    Darrah, C
    Donell, ST
    Shepstone, L
    Porter, S
    Brockbank, SMV
    Edwards, DR
    Parker, AE
    Clark, IM
    ARTHRITIS AND RHEUMATISM, 2004, 50 (01): : 131 - 141
  • [30] Temporal and Spatial Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Following Myocardial Infarction
    Lindsey, Merry L.
    Zamilpa, Rogelio
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (01) : 31 - 41